Can metoprolol raise blood sugar
Pro Research Analysisby 
Searched over 200M research papers
Can Metoprolol Raise Blood Sugar?
Introduction to Metoprolol and Blood Sugar Levels
Metoprolol, a beta-blocker commonly used to treat hypertension and other cardiovascular conditions, has been studied for its effects on blood sugar levels. Understanding these effects is crucial, especially for patients with diabetes or those at risk of developing diabetes.
Metoprolol and Insulin Sensitivity
Several studies have investigated the impact of metoprolol on insulin sensitivity. Research indicates that metoprolol can decrease insulin sensitivity, leading to higher blood glucose levels. For instance, a study involving hypertensive patients found that glucose uptake mediated by insulin decreased significantly when patients were treated with metoprolol . This reduction in insulin sensitivity can contribute to elevated blood sugar levels.
Blood Sugar Control in Diabetic Patients
In diabetic patients, the use of metoprolol has been shown to affect blood sugar control. A study comparing metoprolol with propranolol in hypertensive diabetic patients found that both drugs caused a rise in fasting, noon, and mid-afternoon blood sugar concentrations by 1.0-1.5 mmol/l (18-27 mg/100 ml) . Although the rise was not significantly greater with metoprolol compared to propranolol, it was clinically important in some patients, indicating that metoprolol can indeed raise blood sugar levels in diabetic individuals.
Long-Term Effects on Blood Glucose
Long-term use of metoprolol has also been associated with metabolic abnormalities. A study on patients with diastolic hypertension reported that metoprolol treatment led to an increase in fasting blood glucose and 2-hour postprandial blood glucose levels after 24 months . This suggests that prolonged use of metoprolol can contribute to sustained hyperglycemia.
Experimental Studies on Metoprolol
Experimental studies on animals have further supported these findings. Research on male Wistar rats demonstrated that metoprolol administration resulted in elevated blood glucose levels and decreased glycogen content, which may be related to higher glucose output . These results highlight the potential for metoprolol to induce hyperglycemia as an unwanted side effect.
Conclusion
In summary, metoprolol has been shown to raise blood sugar levels by decreasing insulin sensitivity and causing metabolic abnormalities. This effect is observed in both diabetic and non-diabetic patients, as well as in experimental animal studies. Therefore, careful monitoring of blood glucose levels is recommended for patients undergoing metoprolol treatment, particularly those with diabetes or at risk of developing diabetes.
Sources and full results
Most relevant research papers on this topic